Program Faculty

Margery Gass, MD
Professor of Clinical Obstetrics
and Gynecology
University of Cincinnati College
of Medicine
Director, University Hospital Menopause
and Osteoporosis Center,
Cincinnati, OH
President, North American Menopause
Society (NAMS)

Production services for this newsletter:
KSP Communications, 140 Sherman St,
Third Floor, Fairfield, CT 06824,
(203) 259-2279.
Contact KSP for additional copies.

©Copyright 2003
Virginia Commonwealth University School of Medicine,
Medical College of Virginia Campus,
Virginia Commonwealth University (VCU), Richmond, VA

Website Design and Development
Chris Stephens
Jeanne Schlesinger, M.Ed.

Systems Requirements

- 233MHz Intel Pentium II processor
- 64MB of RAM
- 28.8Kbps modem (audio only)
- 16-bit sound card and speakers
- 65,000-color video display card set to display at 800x600 (video)
- Windows 98, Windows 2000, Windows ME, Windows NT 4.0 with Service Pack 4 or later, Windows XP
- IE 5.0 or later
- Add Macromedia Flash player if not already installed
- Add Real player if not already installed
- Add Adobe Acrobat reader if not already installed

Faculty Disclosure

In compliance with the Standards for Commercial Support of Continuing Medical Education (ACCME), the following faculty report these relationships:

Margery Gass, MD

Research grants, consulting, and/or advisory board –
Duramed, Eli Lilly, GlaxoSmithKline, Merck, Pfizer,
Proctor & Gamble, Wyeth-Ayerst, Aventis,
Ortho-McNeil, Solvay

Accreditation and Educational Credit

The School of Medicine, Virginia Commonwealth University, Medical College of Virginia Campus (VCU), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.

Physicians may claim up to 1.0 hour in Type 1 or Type 2 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license.

VCU designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

This educational activity was planned in accordance with Accreditation Council for Continuing Medical Education (ACCME) Essentials and Standards.

Statement of Educational Need

This activity is designed to respond to the needs of obstetricians/gynecologists and other physicians who care for women at risk for osteoporosis or with established osteoporosis.

Educational Objectives

After reading this newsletter and completing the post-test, the participant should be able to:

• Describe the risks and benefits of hormone replacement therapy (HRT) based on the results of the Women's Health Initiative (WHI) study.



• Describe the effects of the discontinuation of estrogen on bone density and bone markers.



• Compare the relative risk of fractures in women on continuous estrogen therapy since menopause with that in women who took estrogen for less than one year and that in women who never had estrogen therapy.



• Choose appropriate alternatives to HRT in women at risk for osteoporosis

Statement of Educational Method

The educational information is presented in an 8-page newsletter.

Statement of Evaluation Instrument

A 12-question, multiple-choice post-test is used as the evaluation instrument. An activity evaluation questionnaire will be completed by each participant.

Statement of Intended, or Target, Audience

This activity is intended for, but not limited to: endocrinologists and other physicians who care for patients with osteoporosis.

Instructions

To earn 1 hour of category 1 credit, listen to the audio replay of the roundtable discussion, and read the material in this monograph carefully. Complete the activity evaluation and answer the post-test questions on the accompanying questionnaire.

Send the questionnaire in the enclosed envelope to:
OCME REGISTRAR
P.O. Box 980048
Richmond, VA 23298-0048.
FAX: 804/828-7438
ATTN: OSTEO PROGRAM.

Your credit certificate will be returned. Participation is confidential.

Estimated program completion time: 1 hour.

Activity Number: END IN 04 101 03

Release date: April 2003.
Expiration date: March 31, 2005.

Acknowledgement of Commercial Support

Supported by an unrestricted educational grant from Merck & Co., Inc.

Return to [VCU-CME.org]